LEAP-005: A phase II multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors-Results from the colorectal cancer cohort

Autores: Gómez-Roca, C.; Yanez, E.; Im, S. A.; Castañón Álvarez, Eduardo; Senellart, H.; Doherty, M.; García-Corbacho, J.; López, J. S.; Basu, B.; Maurice-Dror, C.; Gill, S. S.; Ghori, R.; Kubiak, P.; Jin, F.; Norwood, K. G.; Chung, H. C.